Lundbeck Foundation portfolio company acquired for USD 230m

Vifor Pharma is acquiring biotech company Sanifit, which Lundbeckfonden Ventures has invested in since 2015.

Photo: PR / Vifor Pharma

Biotech company Sanifit is changing hands after Swiss company Vifor Pharma has made a deal to take over the firm.

Vifor Pharma is paying EUR 205m (USD 230m) upfront to acquire the company, while a number of milestone payments could mean an additional EUR 170m (USD 191m) is added to the sales price.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs